Your browser doesn't support javascript.
loading
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate.
Attard, Gerhardt; de Bono, Johann S; Logothetis, Christopher J; Fizazi, Karim; Mukherjee, Som D; Joshua, Anthony M; Schrijvers, Dirk; van den Eertwegh, Alfons J M; Li, Weimin; Molina, Arturo; Griffin, Thomas W; Kheoh, Thian; Ricci, Deborah S; Zelinsky, Kathy; Rathkopf, Dana E; Scher, Howard I; Ryan, Charles J.
Afiliação
  • Attard G; The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. gerhardt.attard@icr.ac.uk.
  • de Bono JS; The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom.
  • Logothetis CJ; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fizazi K; Institut Gustave Roussy, University of Paris Sud, Villejuif, France.
  • Mukherjee SD; Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada.
  • Joshua AM; Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada.
  • Schrijvers D; Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium.
  • van den Eertwegh AJ; VU University Medical Center, Amsterdam, the Netherlands.
  • Li W; Janssen Research and Development, Spring House, Pennsylvania.
  • Molina A; Janssen Research and Development, Menlo Park, California.
  • Griffin TW; Janssen Research and Development, Los Angeles, California.
  • Kheoh T; Janssen Research and Development, San Diego, California.
  • Ricci DS; Janssen Research and Development, Spring House, Pennsylvania.
  • Zelinsky K; Janssen Research and Development, Spring House, Pennsylvania.
  • Rathkopf DE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
  • Scher HI; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
  • Ryan CJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Clin Cancer Res ; 21(7): 1621-7, 2015 Apr 01.
Article em En | MEDLINE | ID: mdl-25593303
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transativadores / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transativadores / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos